Latest Regulatory Approval News

Rumble Resources Limited has launched a $2 million non-renounceable entitlement offer following a $7 million placement, aiming to fund exploration and development activities at its Western Queen Gold Project. The offer opens on 16 September and closes on 26 September 2025.

New Hope Corporation has updated its 2025 coal resources and reserves, highlighting a significant increase at West Muswellbrook due to a new geological model, while overall reserves remain steady.

betr Entertainment has issued its fourth supplementary bidder’s statement, addressing PointsBet’s recent assertions and confirming key financial consents and cash flow positions amid its ongoing takeover offer.

Marvel Gold Limited has significantly increased its landholding in Tanzania’s Iramba-Sekenke Greenstone Belt, acquiring two new prospecting licences and applying for a third, setting the stage for a maiden drilling campaign.

Celsius Resources has reported significant high-grade copper and gold drilling results at its MCB Project in the Philippines, alongside securing a conditional water permit crucial for advancing project development.

Northern Minerals has released its Definitive Feasibility Study for the Browns Range Heavy Rare Earth Project, confirming an 11-year production plan targeting 181,000 tonnes of rare earth concentrate. The project aims to establish a critical Australian supply chain for heavy rare earths in partnership with Iluka Resources.

Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.

Black Rock Mining Limited has announced a $12 million capital raising via a two-tranche placement and a Share Purchase Plan (SPP) to fund early works at its Mahenge Graphite Project. The offer includes new shares priced at $0.021 each with free options exercisable at $0.03, subject to shareholder approval and ASX quotation.

Forrestania Resources is set to begin a two-phase drilling program at its Hyden Project following regulatory approval and the settlement of legal disputes over tenements.

Zeotech Limited has locked in a binding five-year offtake agreement with MSI, granting exclusive marketing rights for its kaolin products across key Asian markets. This deal, valued at approximately AUD 204 million, sets the stage for early cash flow generation and advancement of its low-carbon concrete additive project.

Yari Minerals has raised $1.5 million through a share placement to fund its first drilling campaign at the South Rolleston Coal Project, aiming to upgrade its coal resource classification and confirm metallurgical quality.

Actinogen Medical has reached a pivotal agreement with the US FDA outlining the regulatory and clinical trial requirements for Xanamem’s approval in Alzheimer’s disease, setting a clear path toward a US marketing application.